chr11-4955080-A-C

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_001004748.1(OR51A2):​c.634T>G​(p.Phe212Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000025 ( 0 hom., cov: 18)
Exomes 𝑓: 0.000070 ( 19 hom. )
Failed GnomAD Quality Control

Consequence

OR51A2
NM_001004748.1 missense

Scores

18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.599

Publications

1 publications found
Variant links:
Genes affected
OR51A2 (HGNC:14764): (olfactory receptor family 51 subfamily A member 2) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
MMP26 (HGNC:14249): (matrix metallopeptidase 26) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.060497373).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OR51A2NM_001004748.1 linkc.634T>G p.Phe212Val missense_variant Exon 1 of 1 ENST00000380371.1 NP_001004748.1 Q8NGJ7A0A126GWD5
MMP26NM_021801.5 linkc.-144-32988A>C intron_variant Intron 2 of 7 ENST00000380390.6 NP_068573.2 Q9NRE1
MMP26NM_001384608.1 linkc.-152-33190A>C intron_variant Intron 2 of 7 NP_001371537.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OR51A2ENST00000380371.1 linkc.634T>G p.Phe212Val missense_variant Exon 1 of 1 6 NM_001004748.1 ENSP00000369729.1 Q8NGJ7
MMP26ENST00000380390.6 linkc.-144-32988A>C intron_variant Intron 2 of 7 5 NM_021801.5 ENSP00000369753.1 Q9NRE1
MMP26ENST00000300762.2 linkc.-152-33190A>C intron_variant Intron 2 of 7 1 ENSP00000300762.2 A0A8J8YUH5

Frequencies

GnomAD3 genomes
AF:
0.0000251
AC:
3
AN:
119434
Hom.:
0
Cov.:
18
show subpopulations
Gnomad AFR
AF:
0.0000281
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000132
AC:
3
AN:
226438
AF XY:
0.0000244
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000293
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000702
AC:
93
AN:
1325484
Hom.:
19
Cov.:
35
AF XY:
0.0000711
AC XY:
47
AN XY:
661204
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32170
American (AMR)
AF:
0.00
AC:
0
AN:
36866
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
34516
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82060
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48968
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5504
European-Non Finnish (NFE)
AF:
0.0000915
AC:
92
AN:
1005404
Other (OTH)
AF:
0.0000180
AC:
1
AN:
55524
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.389
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000251
AC:
3
AN:
119434
Hom.:
0
Cov.:
18
AF XY:
0.0000173
AC XY:
1
AN XY:
57694
show subpopulations
African (AFR)
AF:
0.0000281
AC:
1
AN:
35628
American (AMR)
AF:
0.00
AC:
0
AN:
10434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2790
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3912
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3978
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7304
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
266
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
52998
Other (OTH)
AF:
0.00
AC:
0
AN:
1562
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000805
Hom.:
0
ExAC
AF:
0.0000178
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jul 14, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.634T>G (p.F212V) alteration is located in exon 1 (coding exon 1) of the OR51A2 gene. This alteration results from a T to G substitution at nucleotide position 634, causing the phenylalanine (F) at amino acid position 212 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.071
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
6.1
DANN
Benign
0.34
DEOGEN2
Benign
0.0034
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.029
N
LIST_S2
Benign
0.14
T
M_CAP
Benign
0.0067
T
MetaRNN
Benign
0.060
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
-0.60
PROVEAN
Benign
-0.24
N
REVEL
Benign
0.042
Sift
Benign
1.0
T
Sift4G
Benign
0.89
T
Polyphen
0.20
B
Vest4
0.030
MutPred
0.41
Loss of stability (P = 0.1598);
MVP
0.64
MPC
1.5
ClinPred
0.053
T
GERP RS
0.57
Varity_R
0.069
gMVP
0.13
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs754288409; hg19: chr11-4976310; API